clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Diphtheria D004165 2 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Dermatomycoses D003881 17 associated lipids
Drug Eruptions D003875 30 associated lipids
Dermatitis, Exfoliative D003873 10 associated lipids
Cysts D003560 4 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cross Infection D003428 9 associated lipids
Conjunctivitis, Bacterial D003234 3 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Confusion D003221 4 associated lipids
Colitis D003092 69 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Chlamydia Infections D002690 7 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Bronchitis D001991 6 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Bronchiolitis D001988 6 associated lipids
Bronchiectasis D001987 7 associated lipids
Bronchial Spasm D001986 18 associated lipids
Bradycardia D001919 13 associated lipids
Boutonneuse Fever D001907 5 associated lipids
Body Weight D001835 333 associated lipids
Bartonella Infections D001474 3 associated lipids
Barrett Esophagus D001471 3 associated lipids
Bacteriuria D001437 7 associated lipids
Bacterial Infections D001424 21 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Arthritis D001168 41 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Angina Pectoris D000787 27 associated lipids
Adenocarcinoma D000230 166 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Achlorhydria D000126 1 associated lipids
Abscess D000038 13 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Abnormalities, Drug-Induced D000014 10 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Fujita Y et al. Pulmonary Actinomyces graevenitzii infection presenting as organizing pneumonia diagnosed by PCR analysis. 2012 J. Med. Microbiol. pmid:22516132
Albaugh DR et al. Time-dependent inhibition and estimation of CYP3A clinical pharmacokinetic drug-drug interactions using plated human cell systems. 2012 Drug Metab. Dispos. pmid:22490230
Malfertheiner P et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. 2012 Gut pmid:22491499
Huang YK et al. Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication. 2012 J Dig Dis pmid:22435509
Brož P et al. Nonirritant intradermal skin test concentrations of ciprofloxacin, clarithromycin, and rifampicin. 2012 Allergy pmid:22435670
Hojsak I et al. Antibiotic resistance of Helicobacter pylori in pediatric patients -- 10 years' experience. 2012 Eur. J. Pediatr. pmid:22430353
Koutsoubari I et al. Effect of clarithromycin on acute asthma exacerbations in children: an open randomized study. 2012 Pediatr Allergy Immunol pmid:22433020
Lin YH and Liu TC Mycobacterium chelonae infection involving the auricle. 2012 QJM pmid:21908384
Ji R et al. Mucosal barrier defects in gastric intestinal metaplasia: in vivo evaluation by confocal endomicroscopy. 2012 Gastrointest. Endosc. pmid:22325805
Walkey AJ and Wiener RS Macrolide antibiotics and survival in patients with acute lung injury. 2012 Chest pmid:22116799
Falkinham JO et al. Antibacterial activities of dendritic amphiphiles against nontuberculous mycobacteria. 2012 Tuberculosis (Edinb) pmid:22209468
Raj JM and Raj SM Concern about the efficacy of clarithromycin containing standard triple therapy in the eradication of Helicobacter pylori infection in Malaysia. 2012 Med. J. Malaysia pmid:23770883
Valizadeh H et al. Antibacterial activity of clarithromycin loaded PLGA nanoparticles. 2012 Pharmazie pmid:22393833
Togami K et al. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections. 2012 J Aerosol Med Pulm Drug Deliv pmid:22360316
Shiotani A et al. H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands. 2012 J. Gastroenterol. pmid:22382634
Nujić K et al. Valosin containing protein (VCP) interacts with macrolide antibiotics without mediating their anti-inflammatory activities. 2012 Eur. J. Pharmacol. pmid:22209877
Ding FM et al. Low-dose clarithromycin therapy modulates CD4(+) T-cell responses in a mouse model of chronic Pseudomonas aeruginosa lung infection. 2012 Respirology pmid:22404374
Kadayifci A et al. Low efficacy of clarithromycin including sequential regimens for Helicobacter pylori infection. 2012 Helicobacter pmid:22404442
Gisbert JP and McNicholl AG Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospital. 2012 Helicobacter pmid:22404448
Hiramatsu M et al. Risk factors that affect the surgical outcome in the management of focal bronchiectasis in a developed country. 2012 Ann. Thorac. Surg. pmid:22119119
Salmon JH et al. Discitis and sacroiliitis diagnosed 15 years after iatrogenic Mycobacterium xenopi inoculation. 2012 Joint Bone Spine pmid:22405857
Katayama M et al. Interaction of clarithromycin with cyclosporine in cats: pharmacokinetic study and case report. 2012 J. Feline Med. Surg. pmid:22412163
Zarogoulidis P et al. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. 2012 Eur. J. Clin. Pharmacol. pmid:22105373
Bruin JP et al. Wild-type MIC distribution and epidemiological cut-off values in clinical Legionella pneumophila serogroup 1 isolates. 2012 Diagn. Microbiol. Infect. Dis. pmid:22100012
Togami K et al. Transport characteristics of clarithromycin, azithromycin and telithromycin, antibiotics applied for treatment of respiratory infections, in Calu-3 cell monolayers as model lung epithelial cells. 2012 Pharmazie pmid:22764569
Bondon-Guitton E et al. Drug-induced gingival overgrowth: a study in the French Pharmacovigilance Database. 2012 J. Clin. Periodontol. pmid:22519416
Konorev MR [Use of the immunopotentiator N-acetyl-glucosamine-N-acetylmuramyl dipeptide during triple anti-Helicobacter pylori therapy]. 2012 Ter. Arkh. pmid:23479993
Bosnar M et al. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity. 2012 J. Med. Chem. pmid:22697905
Bai J et al. Erythromycin enhances CD4+Foxp3+ regulatory T-cell responses in a rat model of smoke-induced lung inflammation. 2012 Mediators Inflamm. pmid:22701274
Prechtl J et al. Monitoring of antibiotic resistance rates of Helicobacter pylori in Austrian children, 2002-2009. 2012 Pediatr. Infect. Dis. J. pmid:22094633
Dalkmann P et al. Accumulation of pharmaceuticals, Enterococcus, and resistance genes in soils irrigated with wastewater for zero to 100 years in central Mexico. 2012 PLoS ONE pmid:23049795
Kurugol Z et al. Severe Hemolytic Anemia Associated with Mild Pneumonia Caused by Mycoplasma pneumonia. 2012 Case Rep Med pmid:23049568
Deng ZH et al. Influence of Helicobacter pylori infection on ghrelin levels in children. 2012 World J. Gastroenterol. pmid:23049220
Malfertheiner P et al. Helicobacter pylori: clinical management. 2012 Curr. Opin. Gastroenterol. pmid:23010682
Tepes B et al. Treatment of Helicobacter pylori infection 2012. 2012 Helicobacter pmid:22958154
Al Aukidy M et al. Monitoring release of pharmaceutical compounds: occurrence and environmental risk assessment of two WWTP effluents and their receiving bodies in the Po Valley, Italy. 2012 Sci. Total Environ. pmid:22967493
Sarker SA et al. Influence of Helicobacter pylori infection on gastric acid secretion in pre-school Bangladeshi children. 2012 Helicobacter pmid:22967116
Nishizawa T et al. Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy. 2012 J Clin Biochem Nutr pmid:22962528
Amin M et al. Green synthesis of silver nanoparticles through reduction with Solanum xanthocarpum L. berry extract: characterization, antimicrobial and urease inhibitory activities against Helicobacter pylori. 2012 Int J Mol Sci pmid:22949839
Kurinčič M et al. Epigallocatechin gallate as a modulator of Campylobacter resistance to macrolide antibiotics. 2012 Int. J. Antimicrob. Agents pmid:22999765
Korkmaz S et al. Unusual manifestations of acute Q fever: autoimmune hemolytic anemia and tubulointerstitial nephritis. 2012 Ann. Clin. Microbiol. Antimicrob. pmid:22607576
Whittemore KR and Cohen M Imaging and review of a large pre-auricular pilomatrixoma in a child. 2012 World J Radiol pmid:22761984
Suzuki H et al. Molecular approaches and modern clinical strategies for the management of Helicobacter pylori infection in Japan. 2012 Keio J Med pmid:23324305
Kudo T et al. Comparison of lafutidine and rabeprazole in 7-day second-line amoxicillin- and metronidazole-containing triple therapy for Helicobacter pylori: a pilot study. 2012 Helicobacter pmid:22759327
Roccarina D et al. Different Antibiotic No Culture Eradicating (DANCE) strategy: an easy way to manage H. pylori eradication. 2012 Dig Liver Dis pmid:22743557
Tursi A et al. Efficacy and tolerability of a third-line, levofloxacin-based, 10-day sequential therapy in curing resistant Helicobacter pylori infection. 2012 J Gastrointestin Liver Dis pmid:22720300
Giguère S et al. In vitro synergy, pharmacodynamics, and postantibiotic effect of 11 antimicrobial agents against Rhodococcus equi. 2012 Vet. Microbiol. pmid:22704561
O'Connor MB et al. Rituximab-induced pulmonary disease. 2012 Rheumatol. Int. pmid:21892654
Nakagawa T et al. [Multicenter study on clinical features and genetic characteristics of Mycobacterium avium strains from patients in Japan with lung disease caused by M. avium]. 2012 Kekkaku pmid:23367826
Kumar KV et al. Recurrent insulin injection abscesses: Atypical etiology. 2012 Indian J Endocrinol Metab pmid:22701833
Gochi M et al. [Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report]. 2012 Kekkaku pmid:23367833
Kim BJ et al. Discovery of a novel hsp65 genotype within Mycobacterium massiliense associated with the rough colony morphology. 2012 PLoS ONE pmid:22693637
Fujita M et al. The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease. 2012 J. Infect. Chemother. pmid:21927844
Dobrick N et al. [Legionnaires disease (legionella pneumonia)]. 2012 Praxis (Bern 1994) pmid:23147600
Ratcliffe AT and Ismail KM Intravenous macrolide use: a reminder of the dangers of rapid infusion rates. 2012 J Clin Anesth pmid:23101782
Bermudez LE et al. Identification of (+)-erythro-mefloquine as an active enantiomer with greater efficacy than mefloquine against Mycobacterium avium infection in mice. 2012 Antimicrob. Agents Chemother. pmid:22615290
Khan A et al. Antibiotic resistance and cagA gene correlation: a looming crisis of Helicobacter pylori. 2012 World J. Gastroenterol. pmid:22611319
Brereton AS and El Teraifi H Mycobacterium malmoense: dissemination causes a popliteal aneurysm in a 74-year-old man. 2012 BMJ Case Rep pmid:22602841
Jigorel E and Houston JB Utility of drug depletion-time profiles in isolated hepatocytes for accessing hepatic uptake clearance: identifying rate-limiting steps and role of passive processes. 2012 Drug Metab. Dispos. pmid:22593038
Timour Q et al. Sudden death of cardiac origin and psychotropic drugs. 2012 Front Pharmacol pmid:22590457
Conde-Álvarez R et al. The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition. 2012 PLoS Pathog. pmid:22589715
Suzuki T Meibomitis-related keratoconjunctivitis: implications and clinical significance of meibomian gland inflammation. 2012 Cornea pmid:23038034
Kamada T et al. [Case of acute pharyngitis caused by Corynebacterium ulcerans in Ibaraki Prefecture]. 2012 Nippon Jibiinkoka Gakkai Kaiho pmid:22991854
Ichiki H et al. [A study of adverse drug reactions in the treatment of pulmonary Mycobacterium avium complex disease]. 2012 Kekkaku pmid:22993889
Schluger NW Treatment of pulmonary Mycobacterium avium complex infections: do drug levels matter? 2012 Am. J. Respir. Crit. Care Med. pmid:23071188
Li K and Haber RM Stevens-Johnson syndrome without skin lesions (Fuchs syndrome): a literature review of adult cases with Mycoplasma cause. 2012 Arch Dermatol pmid:22911206
Alfakry H et al. The association of serum neutrophil markers and acute coronary syndrome. 2012 Scand. J. Immunol. pmid:22537345
Shaifali I et al. Antibiotic susceptibility patterns of urinary pathogens in female outpatients. 2012 N Am J Med Sci pmid:22536558
Li H et al. [Clarithromycin combined with tanshinone for rhinosinusal and laryngeal radiation injury in patients with nasopharyngeal carcinoma after radiotherapy]. 2012 Nan Fang Yi Ke Da Xue Xue Bao pmid:22931614
Gisbert JP Rescue Therapy for Helicobacter pylori Infection 2012. 2012 Gastroenterol Res Pract pmid:22536225
Lee MR et al. Otitis media and otomastoiditis caused by Mycobacterium massiliense (Mycobacterium abscessus subsp. bolletii). 2012 J. Clin. Microbiol. pmid:22933592
Lee RP et al. Mycobacterium chelonae infection after total knee arthroplasty: a case report. 2012 J Orthop Surg (Hong Kong) pmid:22535831
van de Streek J Reinterpretation of the monohydrate of clarithromycin from X-ray powder diffraction data as a trihydrate. 2012 Acta Crystallogr C pmid:22935507
Shaaban HS et al. Mycobacterium chelonae infection of the parotid gland. 2012 J Glob Infect Dis pmid:22529633
Farivar TN et al. Assessment of helicobacter pylori prevalence by scorpion real-time PCR in chronic tonsillitis patients. 2012 J Glob Infect Dis pmid:22529626
Buzás GM [Helicobacter pylori - 2012]. 2012 Orv Hetil pmid:22951408
Zheng Q et al. Occurrence and distribution of antibiotics in the Beibu Gulf, China: impacts of river discharge and aquaculture activities. 2012 Mar. Environ. Res. pmid:22525825
Misiewicz JJ Management of Helicobacter pylori-related disorders. 2012 Eur J Gastroenterol Hepatol pmid:22498902
Senhorinho GN et al. Occurrence and antimicrobial susceptibility of Porphyromonas spp. and Fusobacterium spp. in dogs with and without periodontitis. 2012 Anaerobe pmid:22609780
Lee HY et al. Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan. 2012 Subst Abuse Treat Prev Policy pmid:22429858
Lulitanond A et al. Prevalence of β-lactamase-negative ampicillin-resistant haemophilus influenzae isolated from patients of a teaching hospital in Thailand. 2012 Jpn. J. Infect. Dis. pmid:22446118
Liang Y et al. Epidemiological and molecular characteristics of clinical isolates of Streptococcus pyogenes collected between 2005 and 2008 from Chinese children. 2012 J. Med. Microbiol. pmid:22442290
Gomez-Abreo D et al. [Chronic necrotizing pulmonary aspergillosis following an infection by Mycobacterium malmoense]. 2012 Rev Mal Respir pmid:22440310
Shimizu T and Shimizu S Azithromycin inhibits mucus hypersecretion from airway epithelial cells. 2012 Mediators Inflamm. pmid:22577246
Mochizuki Y et al. Chronic mandibular osteomyelitis with suspected underlying synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: a case report. 2012 J Inflamm Res pmid:22427727
Farfan-Portet MI et al. Patient socioeconomic determinants of the choice of generic versus brand name drugs in the context of a reference price system: evidence from Belgian prescription data. 2012 Eur J Health Econ pmid:22427042
Mégraud F The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy. 2012 Therap Adv Gastroenterol pmid:22423259
Guillot S et al. Macrolide-resistant Bordetella pertussis infection in newborn girl, France. 2012 Emerging Infect. Dis. pmid:22608348
Carella AM et al. Clarithromycin potentiates tyrosine kinase inhibitor treatment in patients with resistant chronic myeloid leukemia. 2012 Leuk. Lymphoma pmid:22233113
van Ingen J et al. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment. 2012 Am. J. Respir. Crit. Care Med. pmid:22744719
Kobashi Y et al. Pulmonary Mycobacterium kyorinense disease showed clinical improvement following combined therapy with clarithromycin and levofloxacin. 2012 Intern. Med. pmid:22821114
Morisset J et al. A case of difficult-to-treat eosinophilic asthma controlled with clarithromycin. 2012 Ann. Allergy Asthma Immunol. pmid:22727169
Calza P et al. Identification of the unknown transformation products derived from clarithromycin and carbamazepine using liquid chromatography/high-resolution mass spectrometry. 2012 Rapid Commun. Mass Spectrom. pmid:22730089
Pereyre S et al. Clonal spread of Mycoplasma pneumoniae in primary school, Bordeaux, France. 2012 Emerging Infect. Dis. pmid:22305177
Butler CC et al. Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. 2012 BMJ pmid:22302780
Anand TD et al. Superantigen profiles of emm and emm-like typeable and nontypeable pharyngeal streptococcal isolates of South India. 2012 Ann. Clin. Microbiol. Antimicrob. pmid:22296671
Trigo P and Fischer GW Managing atrial fibrillation in the elderly: critical appraisal of dronedarone. 2012 Clin Interv Aging pmid:22291468
Correia M et al. Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization. 2012 PLoS ONE pmid:22529974
Altman JK and Platanias LC A new purpose for an old drug: inhibiting autophagy with clarithromycin. 2012 Leuk. Lymphoma pmid:22288786
Polat Z et al. Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori. 2012 Eur. J. Intern. Med. pmid:22284248